AngioDynamics Inc (STU:UG2)
€ 5.9 0.05 (0.85%) Market Cap: 229.90 Mil Enterprise Value: 181.36 Mil PE Ratio: 0 PB Ratio: 1.16 GF Score: 57/100

AngioDynamics Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript

Mar 22, 2022 / 07:45PM GMT
Release Date Price: €20.4 (-0.97%)
Matt Mishan
KeyBanc Capital Markets - Analyst

Hey, good afternoon. I'd like to welcome everyone to the last meeting of the first day of the KeyBanc Life Sciences & MedTech Investor Forum. My name is Matt Mishan; I'm a senior medtech analyst. And I'm pleased to be joined by AngioDynamics, which is represented today by its CEO, Jim Clemmer; and CFO, Steve Trowbridge.

For the audience, I'll start this off, but questions can be submitted directly to me by typing into the box below the video stream, and I can relay. With that, I'll open it up with you guys.

Questions & Answers

Matt Mishan
KeyBanc Capital Markets - Analyst

You are reporting earnings in a couple of weeks, and I will wait for more detail then, but just -- could you just briefly describe how procedural trends have progressed over the past several months?

Jim Clemmer
AngioDynamics, Inc. - President & CEO

Sure. And thanks, Matt, for KeyBanc sponsoring an excellent conference today. Thanks for the invitation to your conference.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot